X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
humans (10) 10
female (9) 9
male (9) 9
aged (8) 8
medicine, general & internal (7) 7
abridged index medicus (6) 6
cardiovascular disease (6) 6
drug therapy, combination (6) 6
middle aged (6) 6
cardiovascular diseases - mortality (5) 5
double-blind method (5) 5
drug therapy (5) 5
risk factors (5) 5
stroke (5) 5
anticoagulants (4) 4
atrial fibrillation (4) 4
clinical trials (4) 4
coronary artery disease (4) 4
hemorrhage - chemically induced (4) 4
mortality (4) 4
myocardial infarction (4) 4
patients (4) 4
platelet aggregation inhibitors - therapeutic use (4) 4
prevention (4) 4
risk (4) 4
stroke - epidemiology (4) 4
acute coronary syndromes (3) 3
aspirin (3) 3
aspirin - adverse effects (3) 3
aspirin - therapeutic use (3) 3
atrial fibrillation - drug therapy (3) 3
cardiac arrhythmia (3) 3
cardiovascular diseases (3) 3
cardiovascular diseases - prevention & control (3) 3
cerebral infarction (3) 3
coronary vessels (3) 3
disease prevention (3) 3
factor xa inhibitors - adverse effects (3) 3
factor xa inhibitors - therapeutic use (3) 3
fibrillation (3) 3
heart attacks (3) 3
heart diseases (3) 3
life sciences (3) 3
medical research (3) 3
morbidity (3) 3
platelet aggregation inhibitors - administration & dosage (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
rivaroxaban (3) 3
rivaroxaban - adverse effects (3) 3
rivaroxaban - therapeutic use (3) 3
stroke - prevention & control (3) 3
therapy (3) 3
aged, 80 and over (2) 2
algorithms (2) 2
aspirin - administration & dosage (2) 2
atherosclerosis - drug therapy (2) 2
blood pressure (2) 2
cardiovascular diseases - drug therapy (2) 2
clinical outcomes (2) 2
clopidogrel (2) 2
cohort studies (2) 2
coronary artery (2) 2
coronary artery disease - drug therapy (2) 2
diabetes mellitus (2) 2
disease control (2) 2
dose-response relationship, drug (2) 2
drug administration schedule (2) 2
drug dosages (2) 2
drugs (2) 2
electrocardiography (2) 2
endothelial dysfunction (2) 2
factor xa inhibitors (2) 2
factor xa inhibitors - administration & dosage (2) 2
follow-up studies (2) 2
health risk assessment (2) 2
heart (2) 2
hemorrhage (2) 2
human health and pathology (2) 2
hypertension (2) 2
incidence (2) 2
journal article (2) 2
mao inhibitors (2) 2
monoamine oxidases (2) 2
myocardial infarction - epidemiology (2) 2
myocardial infarction - prevention & control (2) 2
oral rivaroxaban (2) 2
platelet aggregation inhibitors (2) 2
rivaroxaban - administration & dosage (2) 2
romania - epidemiology (2) 2
sleep apnea syndromes - complications (2) 2
studies (2) 2
thromboembolism (2) 2
treatment outcome (2) 2
ventricle (2) 2
volume (2) 2
adenocarcinoma (1) 1
adherent antithrombotic treatment (1) 1
administration, oral (1) 1
adrenoceptor (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Anand, Sonia S and Bosch, Jackie and Eikelboom, John W and Connolly, Stuart J and Diaz, Rafael and Widimsky, Peter and Aboyans, Victor and Alings, Marco and Kakkar, Ajay K and Keltai, Katalin and Maggioni, Aldo P and Lewis, Basil S and Störk, Stefan and Zhu, Jun and Lopez-Jaramillo, Patricio and O'Donnell, Martin and Commerford, Patrick J and Vinereanu, Dragos and Pogosova, Nana and Ryden, Lars and Fox, Keith A A and Bhatt, Deepak L and Misselwitz, Frank and Varigos, John D and Vanassche, Thomas and Avezum, Alvaro A and Chen, Edmond and Branch, Kelley and Leong, Darryl P and Bangdiwala, Shrikant I and Hart, Robert G and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ... and COMPASS Investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 219 - 229
Patients with peripheral artery disease have an increased risk of cardiovascular morbidity and mortality. Antiplatelet agents are widely used to reduce these... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | MANAGEMENT | THERAPY | OUTPATIENTS | CARDIOVASCULAR EVENT RATES | PREVENTION | RISK | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Carotid Artery Diseases - complications | Male | Peripheral Arterial Disease - complications | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Lower Extremity - surgery | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Myocardial Infarction - etiology | Rivaroxaban - therapeutic use | Carotid Artery Diseases - drug therapy | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Peripheral Arterial Disease - drug therapy | Carotid Artery Diseases - epidemiology | Morbidity | Factor Xa Inhibitors - therapeutic use | Stroke - etiology | Peripheral Arterial Disease - epidemiology | Factor Xa Inhibitors - adverse effects | Aged | Myocardial Infarction - prevention & control | Amputation - statistics & numerical data | Hemorrhage - chemically induced | Lower Extremity - blood supply | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Heart attacks | Medical imaging | Mortality | Clinical trials | Cardiovascular disease | Patients | Disease control | Carotid arteries | Disease prevention | Coronary vessels | Blood pressure | Carotid artery | Acute coronary syndromes | Thromboembolism | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
by Connolly, Stuart J and Eikelboom, John W and Bosch, Jackie and Dagenais, Gilles and Dyal, Leanne and Lanas, Fernando and Metsarinne, Kaj and O'Donnell, Martin and Dans, Anthony L and Ha, Jong-Won and Parkhomenko, Alexandr N and Avezum, Alvaro A and Lonn, Eva and Lisheng, Liu and Torp-Pedersen, Christian and Widimsky, Petr and Maggioni, Aldo P and Felix, Camilo and Keltai, Katalin and Hori, Masatsugu and Yusoff, Khalid and Guzik, Tomasz J and Bhatt, Deepak L and Branch, Kelley R H and Cook Bruns, Nancy and Berkowitz, Scott D and Anand, Sonia S and Varigos, John D and Fox, Keith A A and Yusuf, Salim and SALA, JORGELINA and CARTASEGNA, LUIS and VICO, MARISA and HOMINAL, MIGUEL ANGEL and HASBANI, EDUARDO and CACCAVO, ALBERTO and ZAIDMAN, CESAR and VOGEL, DANIEL and HRABAR, ADRIAN and SCHYGIEL, PABLO OMAR and CUNEO, CARLOS and LUQUEZ, HUGO and MACKINNON, IGNACIO J and AHUAD GUERRERO, RODOLFO ANDRES and COSTABEL, JUAN PABLO and BARTOLACCI, INES PALMIRA and MONTANA, OSCAR and BARBIERI, MARIA and GOMEZ VILAMAJO, OSCAR and GARCIA DURAN, RUBEN OMAR and SCHIAVI, LILIA BEATRIZ and GARRIDO, MARCELO and INGARAMO, ADRIAN and BORDONAVA, ANSELMO PAULINO and PELAGAGGE, MARIA JOSE and NOVARETTO, LEONARDO and ALBISU DI GENNERO, JUAN PABLO and IBANEZ SAGGIA, LUZ MARIA and ALVAREZ, MOIRA and VITA, NESTOR ALEJANDRO and MACIN, STELLA MARIS and DRAN, RICARDO DARIO and CARDONA, MARCELO and GUZMAN, RANDOLPH and GUZMAN, LUIS and SARJANOVICH, RODOLFO JUAN and CUADRADO, JESUS and NANI, SEBASTIAN and LITVAK BRUNO, MARCOS RAUL and CHACON, CAROLINA and MAFFEI, LAURA ELENA and GRINFELD, DIEGO and VENSENTINI, NATALIA and MAJUL, CLAUDIO RODOLFO and LUCIARDI, HECTOR LUCAS and GONZALEZ COLASO, PATRICIA DEL CARMEN and FERRE PACORA, FREDY ANTONI and VAN DEN HEUVEL, PAUL and VERHAMME, PETER and ECTOR, BAVO and DEBONNAIRE, PHILIPPE and VAN DE BORNE, PHILIPPE and LEROY, JEAN and SCHROE, HERMAN and VRANCKX, PASCAL and ELEGEERT, IVAN and HOFFER, ETIENNE and DUJARDIN, KARL and INDIO DO BRASIL, CLARISSE and PRECOMA, DALTON and ABRANTES, JOSE ANTONIO and MANENTI, EULER and REIS, GILMAR and SARAIVA, JOSE and MAIA, LILIA and HERNANDES, MAURO and ROSSI, PAULO and ROSSI DOS SANTOS, FABIO and ZIMMERMANN, SERGIO LUIZ and RECH, RAFAEL and ... and COMPASS Investigators and COMPASS investigators
The Lancet, ISSN 0140-6736, 01/2018, Volume 391, Issue 10117, pp. 205 - 218
Coronary artery disease is a major cause of morbidity and mortality worldwide, and is a consequence of acute thrombotic events involving activation of... 
PREVENTION | MEDICINE, GENERAL & INTERNAL | ORAL RIVAROXABAN | Myocardial Infarction - epidemiology | Cardiovascular Diseases - prevention & control | Humans | Male | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Dose-Response Relationship, Drug | Rivaroxaban - adverse effects | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Coronary Artery Disease - drug therapy | Morbidity | Factor Xa Inhibitors - therapeutic use | Factor Xa Inhibitors - adverse effects | Aged | Coronary Artery Disease - epidemiology | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Anticoagulants | Aspirin | Stroke | Heart attacks | Mortality | Coronary artery | Clinical trials | Cardiovascular disease | Coronary artery disease | Disease control | Disease prevention | Coronary vessels | Acute coronary syndromes | Thromboembolism | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 24, pp. 2268 - 2276
Patients with permanent atrial fibrillation and additional cardiac risk factors were randomly assigned to receive either dronedarone or placebo. At a median of... 
HEART | ARRHYTHMIAS | MORTALITY | ADRENOCEPTOR | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SR-33589 | AMIODARONE-LIKE AGENT | Follow-Up Studies | Humans | Anti-Arrhythmia Agents - blood | Hospitalization - statistics & numerical data | Male | Amiodarone - adverse effects | Heart Rate - drug effects | Stroke - chemically induced | Amiodarone - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Drug Therapy, Combination | Digoxin - blood | Digoxin - therapeutic use | Heart Failure - epidemiology | Double-Blind Method | Atrial Fibrillation - drug therapy | Risk Factors | Anti-Arrhythmia Agents - therapeutic use | Amiodarone - analogs & derivatives | Atrial Fibrillation - blood | Anti-Arrhythmia Agents - adverse effects | Atrial Flutter - drug therapy | Aged | Cardiovascular Diseases - chemically induced | Chronic Disease | Heart Failure - chemically induced | Drugs | Product/Service Evaluations | Drug therapy | Atrial fibrillation | Heart failure | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Medical research | Arrhythmia | Risk groups | Cardiovascular disease | Hospitalization | Embolism | Risk factors | Heart rate | Sinuses | Fibrillation | Death | Blood pressure | Ventricle | Acute coronary syndromes | Heart diseases | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
by Vinereanu, Dragos and Lopes, Renato D and Bahit, M Cecilia and Bahit, María Cecilia and Xavier, Denis and Jiang, Jie and Al-Khalidi, Hussein R and He, Pengkang and He, Wensheng and Xian, Ying and Ciobanu, Andrea O and Kamath, Deepak Y and Fox, Kathleen A and Rao, Malipeddi Bhaskara and Rao, Kodem Damodara and Rao, Meena P and Pokorney, Sean D and Berwanger, Otavio and Tajer, Carlos and de Barros e Silva, Pedro Gabriel Melo and de Barros e Silva, Pedro G M and Roettig, Mayme L and Huo, Yong and Granger, Christopher B and Carbajales, Justo and Gómez, Mariela Soledad and Gómez, Javier Neri Ceferino and Principato, Mario Bruno and Von Wulffen, María Alejandra and Acunzo, Jorge Galperín Rafael Salvador and Bonato, Ricardo Renato and Ciampi, Natalia and Marani, Alberto Babil and Panigadi, Cristian Gustavo and Pastura, Silvia Gabriela and Onetto, Leonardo Martín and Moya, Cecilia Rafaela and Budassi, Nadia and Valle, Marisol and Camerini, Daniel and Monjes, Enrique and Zabala, Federico and Ricart, Juan Pablo and Medesani, Luis and Campos, Eduardo Noe Ortuño and Ferroni, Fabián and Torres, Mariana Foa and Fassi, Daniel Omar and Bosio, Fernando Javier Díaz and Baztarrica, Gabriel Edgardo Pérez and Infantas, Teresa Zúñiga and Perlo, Daniela and García, Marilia and García, Celso Fernando and Durán, Luisina García and Durán, Rubén García and Pettinari, Cecilia Alejandra and Vico, Marisa Liliana and Lanchiotti, Paulina Virginia and Poy, Carlos Alberto and Poy, María Laura and Grazziani, Franco Sebastián and Laspina, Marcela Julieta and Egydio, Flávia and Restelli, Elissa and Kawakami, Anelise and Soares, Tamara Colaiácovo and Valois, Mayara Vioto and Duarte, Tauane Bello and Barbosa, Lilian Mazza and Barbosa, Luiz Carlos Vianna and de Paola, Angelo Amato Vicenzo and Pimenta, Thiago Librelon and Jeronimo, Gabriela Dal Moro and da Costa, Bruna S. Fernandes and Coutinho, Enia Lucia and Guerrero, Andressa Zulmira A and Maia, Lilia Nigro and Nakazone, Marcelo Arruda and Lemos, Maria Angelica Teixeira and Costa, Osana Maria Coelho and Demore, Ana Paula and Brito, Roberta Parra and Melo, Camila Dal Bon and Góes, Nadielly Codonho and Lorenço, Osvaldo and Gonçalves, Luiz Otavio Maia and Nishiama, Kátia and de Lima, Tiago Aparecido Maschio and Backes, Luciano Marcelo and de Lima Deucher, Keyla Liliana Alves and Rodrigues, Milena Pozzatto and Baldissera, Dunnia Monisa and Reolão, José Basileu Caos and dos Santos, Tais Alves and Freisleben, Fernanda Michel Birck and da Silveira Kaross, Níncia Lucca and Montovani, Jéssika Tzervieczenski and Cantarelli, Maiara and Lucion, Aline and ... and IMPACT-AF Investigators and IMPACT-AF investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1737 - 1746
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article